Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling, Phase
Updated: 12/31/1969
Renovatio Clinical
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Indiana Univeristy Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Malignant Biliary Obstruction Clinical Trial
A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Commack (Consent only)
mi
from
Commack, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of GEN-1 With NACT for Treatment of Ovarian Cancer (OVATION 2)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
West Penn Hospital, Allegheny Health Network
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799).
Status: Enrolling, Phase II
Updated: 12/31/1969
Blacktown Hospital Western Sydney Local Health District
mi
from
Blacktown,
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Trial of eRapa in Prostate Cancer Patients
Status: Enrolling, Phase I
Updated: 12/31/1969
UT Health San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Status: Enrolling, Phase III
Updated: 12/31/1969
Precision Cancer Research/Dayton Physicians Network - Treatment
mi
from
Kettering, OH
Click here to add this to my saved trials
Oncology Clinical Trial
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Caro Cancer Center
mi
from
Caro, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Trinity Regional Medical Center
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwell Health- Center for Advanced Medicine
mi
from
Lake Success, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sechler Family Cancer Center
mi
from
Lebanon, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hope Cancer Clinic
mi
from
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Ontario
mi
from
Ontario, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Presbyterian Rust Medical Center/Jorgensen Cancer Center
mi
from
Rio Rancho, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Rochester Hills
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at Christian Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital South
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Bon Secours Health Center at Harbour View
mi
from
Suffolk, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Novant Health Oncology Specialists-Davidson County
mi
from
Thomasville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Macomb Hematology Oncology PC
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Arizona Oncology
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Compare Fallopian Tube Cells Collected by MAKO 7 With Removed Ovarian/Tubal Tissue to Determine Presence of Malignant or Benign Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Baylor Scott & White Research Institute
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
US Oncology Investigational Products Center (IPC)
mi
from
Irving, TX
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Institute of New Jersey at University Hospital
mi
from
Newark, NJ
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
University Hospital, Ambulatory Care Center
mi
from
Newark, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Personal Resilience Empowerment Program Study
Status: Enrolling
Updated: 12/31/1969
Hackensack Meridian Health/Jersey Shore University Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study To Evaluate Escalating Doses of A Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC
Status: Enrolling, Phase I
Updated: 12/31/1969
Siteman Cancer Center-St. Peters
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Moores Cancer Center at UC San Diego Health
mi
from
La Jolla, CA
Click here to add this to my saved trials
Cancer Survivors Clinical Trial
Mind Body Program for Fear of Recurrence
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medial Center
mi
from
Boston, MA
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Toledo, Eleanor N. Dana Cancer Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Advanced Non-Small Cell Lung Cancer Clinical Trial
A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)
Status: Enrolling, Phase II
Updated: 12/31/1969
Arizona Oncology Associates, PC - HAL
mi
from
Tempe, AZ
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kennewick, WA
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orange City, FL
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior VEGFR-targeted Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Exelixis Clinical Site #1
mi
from
Houston, TX
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior VEGFR-targeted Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Exelixis Clinical Site #15
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
A Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Community Cancer Trials of Utah
mi
from
Ogden, UT
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fullerton, CA
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Westwood, KS
Click here to add this to my saved trials
Adult Soft Tissue Sarcoma Clinical Trial
Preoperative vs Postoperative IMRT for Extremity/Truncal STS
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Advanced Ovarian Cancer Clinical Trial
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Advanced Ovarian Cancer Clinical Trial
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Advanced Ovarian Cancer Clinical Trial
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Foothill Ranch, CA
Click here to add this to my saved trials
Advanced Ovarian Cancer Clinical Trial
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Advanced Ovarian Cancer Clinical Trial
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Advanced Ovarian Cancer Clinical Trial
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Advanced Ovarian Cancer Clinical Trial
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Myelodysplastic Syndrome Clinical Trial
Expanded Access for ACE-011
Status: Enrolling, Phase
Updated: 12/31/1969
Celgene
mi
from
Summit, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Therapy and Research Center CTRC at UTHSCSA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas Health Science Center- McGovern Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling, Phase
Updated: 12/31/1969
Focilmed
mi
from
Oxnard, CA
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling, Phase
Updated: 12/31/1969
Comprehensive Internal Medicine, Inc.
mi
from
Wooster, OH
Click here to add this to my saved trials
Cancer Clinical Trial
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
Carolina BioOncology Institute, PLCC
mi
from
Huntersville, NC
Click here to add this to my saved trials
Cancer Clinical Trial
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
Memorial Sloan Kettering - Basking Ridge
mi
from
New York, NY
Click here to add this to my saved trials
Solid Tumor Clinical Trial
A Study of LY3405105 in Participants With Advanced Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Princess Margaret Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Neoplasms Clinical Trial
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Melbourne,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
Status: Enrolling, Phase I
Updated: 12/31/1969
DF/BWCC in clinical affiliation with South Shore Hospital
mi
from
South Weymouth, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer and Gynecologic Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Austin, TX
mi
from
Austin, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
San Antonio, TX
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
MGD019 DART® Protein in Unresectable/Metastatic Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
START Midwest
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Neoplasm Malignant Clinical Trial
Evaluation of SAR408701 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Innovative Clinical Research Institute (ICRI)
mi
from
Whittier, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Randomized Study of NKTR-214 Plus Nivolumab and of Reference Chemotherapy in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer With Low PD-L1 Expression
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigator Site - Whittier
mi
from
Whittier, CA
Click here to add this to my saved trials
Oncology Clinical Trial
The Efficacy and Safety of UGN-102 as a Primary Chemoablation Therapy in Patients With LG NMIBC at Intermediate Risk of Recurrence
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Medical Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Gastric Cancer Clinical Trial
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hartford Healthcare Cancer Institute at The Hospital of Central Connecticut
mi
from
Plainville, CT
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Baylor Scott & White All Saints
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Southern Therapy and Advanced Research
mi
from
Jackson, MS
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Schiff Center for Liver Diseases
mi
from
Miami, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
The University of Kansas Cancer Center, Overland Park Clinic
mi
from
Overland Park, KS
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Oncology Clinical Trial
Post-Operative Outcomes of Low Thermal Dissection vs. Traditional Electrosurgery
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital Outpatient Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients
Status: Enrolling, Phase
Updated: 12/31/1969
Animated Dynamics, Inc.
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Colo-rectal Cancer Clinical Trial
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas Health Science Center- McGovern Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Colo-rectal Cancer Clinical Trial
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
Status: Enrolling, Phase
Updated: 12/31/1969
Focilmed
mi
from
Oxnard, CA
Click here to add this to my saved trials
Colo-rectal Cancer Clinical Trial
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
Status: Enrolling, Phase
Updated: 12/31/1969
Comprehensive Internal Medicine, Inc.
mi
from
Wooster, OH
Click here to add this to my saved trials
Neoplasms Clinical Trial
First Time in Humans (FTIH) Study of GSK3368715 in Subjects With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)
Status: Enrolling, Phase I
Updated: 12/31/1969
GSK Investigational Site
mi
from
Melbourne,
Click here to add this to my saved trials
Stomach Neoplasms Clinical Trial
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care ( Site 8000)
mi
from
Roanoke, VA
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Rcca Md, Llc
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab for Pediatric Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab for Pediatric Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of XL092 in Subjects With Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Exelixis Clinical Site #10
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of XL092 in Subjects With Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Exelixis Clinical Site #1
mi
from
Houston, TX
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southdale Cancer Care, University of Minnesota Medical Center- Edina ( Site 0048)
mi
from
Edina, MN
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Status: Enrolling, Phase III
Updated: 12/31/1969
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Oncology Associates (Summit Cancer Centers) ( Site 0014)
mi
from
Spokane, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Status: Enrolling, Phase III
Updated: 12/31/1969
CTCA Southwestern ( Site 0060)
mi
from
Tulsa, OK
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Melbourne,
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Collection and Distribution of Biospecimens for Novel Research Uses
Status: Enrolling, Phase
Updated: 12/31/1969
iSpecimen
mi
from
Lexington, MA
Click here to add this to my saved trials
Locally Advanced Cervical Cancer Clinical Trial
Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials